Peptide Therapy Insights
Evidence-based guides, regulatory updates, and expert perspectives on peptide therapy. Stay informed with the latest research and clinical insights.
How to Reconstitute BPC-157: Step-by-Step Mixing Guide (2026)
A detailed, clinician-informed guide to BPC-157 reconstitution — covering diluent selection, step-by-step mixing instructions, concentration math with worked examples, storage requirements, and common mistakes that destroy peptide potency.
Latest Articles
Peptide Sciences Shuts Down: What Happened and What It Means
Peptide Sciences, the largest grey-market research peptide vendor in the US, voluntarily shut down on March 6, 2026. Here is what happened, why it closed, and what the closure means for researchers and the broader peptide industry.
How to Get Retatrutide in 2026 (Legit Options & Safety Checklist)
Looking for where to buy retatrutide for research use? Here’s a supplier checklist (COAs, testing, reviews, red flags) plus the clinical-trial pathway for legitimate access.
US Injectable Peptides Craze: What Patients Need to Know
The injectable peptides craze is sweeping the US, with many individuals experimenting for various health benefits. Learn the key facts and implications for patients.
Are Peptides the Health Solution Influencers Claim?
Social media influencers rave about peptides for health benefits. But what does scientific research actually say? Discover the truth behind the hype.
How Much BAC Water for Retatrutide? (10 mg Reconstitution Guide)
For a 10 mg retatrutide vial, add 2 mL of bacteriostatic water for a 5 mg/mL concentration. At a 2 mg starting dose, that's 40 units on a 100-unit syringe. Full table + step-by-step guide inside.
NewsUnproven Peptides Gain Popularity: Risks and Concerns
The influence of social media is driving the popularity of unproven peptides, raising concerns among medical professionals. Discover the risks and what this means for patients.
RegulatoryFDA's Crackdown on Compounded GLP-1 Drugs: What Patients Need to Know in 2026
The FDA removed semaglutide and tirzepatide from its drug shortage list in early 2025, ending the compounding exemption that had allowed hundreds of pharmacies to produce GLP-1 copies at lower cost. Here's what that means for your access, your wallet, and your options right now.
RegulatoryFDA Peptide Regulations Explained: What's Actually Regulated in 2026
The FDA's regulatory framework for peptides is more complex — and more consequential — than most patients realize. Here's what's actually regulated, what isn't, and what you need to know before starting any peptide therapy in 2026.
Stay Up to Date
New articles on peptide therapy, FDA regulations, and clinic reviews are published regularly. Bookmark this page or check back often.